安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Charcot–Leyden crystals - Wikipedia
Charcot–Leyden crystals are microscopic crystals composed of eosinophil protein galectin-10 found in people who have allergic diseases such as asthma or parasitic infections such as parasitic pneumonia or ascariasis
- Charcot-Leyden crystals: An ancient but never so current discovery
In particular, to date not only eosinophils but also mast cells are known to be responsible for the production of CLCs, which represent the crystallized form of Galectin-10 Due to their characteristics, CLCs typically induce a crystallopathy and are responsible for an exacerbation of inflammation
- Charcot-Leyden Crystals in Eosinophilic Inflammation: Active . . . - Springer
In 1853, slender needle-like crystals were first reported by Jean-Martin Charcot who found the crystals in cardiac blood and spleen of a patient with leukemia In 1872, Ernst Viktor von Leyden also described similar crystals in the sputum of asthmatic patients
- Charcot-Leyden crystal formation is closely associated with eosinophil . . .
Key Points This research reveals, for the first time, an active process by which CLCs are formed in eosinophilic diseases
- What Are Charcot Leyden Crystals? - iCliniq
Charcot Leyden crystals are hexagonal bipyramidal crystals mainly found in eosinophils and basophils cytoplasm These crystals are primarily associated with inflammation and disorders involving the degeneration of eosinophils
- Charcot-Leyden crystal formation is closely associated with eosinophil . . .
Protein crystallization in human tissue rarely occurs Charcot-Leyden crystals (CLCs) were described in various eosinophilic diseases >150 years ago, but our understanding of CLC formation still remains limited
- Charcot-Leyden Crystals - an overview | ScienceDirect Topics
Charcot-Leyden crystals are slender, pointed protein aggregates of lysolecithin acylhydrolase that can be up to 50 µm in length, typically found in conditions with eosinophilic inflammation or proliferation, often in association with eosinophils
- Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis . . .
Charcot-Leyden crystals (CLCs), slender bipyramidal hexagonal crystals, were first described by Jean-Martin Charcot in 1853, predating Paul Ehrlich’s “discovery” of eosinophils by 26 years To date, CLCs are known as a classical hallmark of eosinophilic inflammation
|
|
|